Skip to content
Screener

PP&E (Net) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$3.1B-1.1%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$8.77M-17.0%
Sotera Health logo
Sotera HealthSHC
$1.17B+8.1%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$157.19M-15.7%
Revvity logo
RevvityRVTY
$465.64M-4.3%
IQVIA logo
IQVIAIQV
$547M+2.1%

Segments

By geography

See full
Europe$396.87M-12.2%
Asia Pacific$60.57M-5.6%
Other$42.36M+5.6%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026December 27, 2025
Furniture and fixtures23,52827,873
Computer hardware and software (1)287,586284,913
Vehicles (1)5,9047,152
Construction in progress135,503171,604
Total2,955,1563,192,922
Less: Accumulated depreciation(1,460,242)(1,537,703)
Property, plant and equipment, net$1,494,914$1,655,219
(1) These balances include assets under finance leases.

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's PP&E (net)?
Charles River Laboratories (CRL) reported PP&E (net) of $1.49B in Q2 2026.
How has Charles River Laboratories's PP&E (net) changed year-over-year?
Charles River Laboratories's PP&E (net) decreased by 7.0% year-over-year, from $1.61B to $1.49B.
What is the long-term trend for Charles River Laboratories's PP&E (net)?
Over 5 years (2020 to 2025), Charles River Laboratories's PP&E (net) has grown at a 8.0% compound annual growth rate (CAGR), from $1.12B to $1.66B.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Charles River Laboratories's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude